Zion Market Research Global Enzyme-Linked Immunosorbent Assay (ELISA) T | Page 4

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market
The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is segmented on the
basis of different test types such as sandwich ELISA, indirect ELISA, multiple and portable
ELISA and competitive ELISA. Indirect ELISA segment is expected to grow at fastest rate in
the global market over the forecast period.
Immunology, inflammation, infectious diseases, cancer, protein quantification and other are
the key applications of the global ELISA testing Market. The immunology segment
dominated the market in terms of revenue in 2016.
North America, Europe, Asia-Pacific, Latin America and Middle East & Africa are key
regional segments of global Enzyme-Linked Immunosorbent Assay (ELISA) testing market.
North America is anticipated to remain the leading region over the forecast period. Demand
for ELISA technologies was highest in North America especially in the U.S. Asia Pacific is
expected to be the fasted growing region in Enzyme-Linked Immunosorbent Assay (ELISA)
testing market during the forecast period. Moreover, the Middle East and Africa and Latin
America are also expected to show considerable growth for this market in the years to
come.
Some of the key players in Enzyme-Linked Immunosorbent Assay (ELISA) testing market
include Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO),
BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R
& D Systems Inc. and ZEUS Scientific, Inc. among others.
Request a customized copy of report @
https://www.zionmarketresearch.com/custom/1978